Disturbances of sleep and wakefulness associated with the use of antihypertensive agents.
Sleep disturbances are frequently associated with the use of antihypertensive drugs. They are observed mainly during the administration of drugs that affect central adrenergic mechanisms. Beta-adrenoceptor antagonists which readily penetrate into the brain (propranolol, pindolol) increase wakefulness and/or decrease REM sleep. Alpha 2-adrenoceptor agonists (clonidine, guanfacine) markedly reduce the duration of REM sleep. The catecholamine depleting agent reserpine increases REM sleep during single or repeated-dose administration, while the MAOI phenelzine shows opposite effects. The 5-HT2 antagonist ritanserin, which is chemically related to the antihypertensive agent ketanserin, increases slow wave sleep while REM sleep is decreased. Sleep disturbances have not been reported during the administration of calcium entry antagonists. However, they seem to modify the effects of hypnotics and CNS stimulants. There are no formal studies on the effects of angiotensin converting enzyme inhibitors and vasodilators on sleep in man.
D000316:Adrenergic alpha-Agonists / Q000009:adverse effects / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000494:pharmacology; D002118:Calcium / Q000037:antagonists & inhibitors; D002395:Catecholamines / Q000037:antagonists & inhibitors; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000494:pharmacology; D011985:Receptors, Serotonin / Q000187:drug effects; D012893:Sleep Wake Disorders / Q000139:chemically induced*; D012895:Sleep, REM / Q000187:drug effects; D014851:Wakefulness / Q000187:drug effects*
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D011985:Receptors, Serotonin; D002118:Calcium